Literature DB >> 1693372

Production of gastrin-releasing peptide-(18-27) and a stable fragment of its precursor in small cell lung carcinoma cells.

A J Vangsted1, T W Schwartz.   

Abstract

The production and postsecretory stability of gastrin-releasing peptide (GRP) and the C-terminal part of the GRP precursor were studied in small cell lung cancer cell lines using RIAs developed against these two parts of the precursor. In three otherwise different cell lines (NIC-H345, NIC-H69, and NIC-H510), similar chromatographic patterns of mainly GRP-(18-27) and some GRP-(14-27) along with large fragments of the C-terminal counterpart of the precursor were found to be stored in the cells. In tissue culture medium, gel filtration chromatography indicated that postsecretory limited proteolysis of the GRP precursor fragments occurred. The amount of accumulated immunoreactivity varied among the three cell lines and between the two parts of the precursor. In medium in which only low amounts of GRP immunoreactivity accumulated, the radiolabeled GRP was degraded rapidly. When incubated with plasma, GRP-(14-27) disappeared within a few hours, whereas the C-terminal precursor fragments were stable. It is concluded that the postsecretory stability of peptides excised from the GRP precursor in small cell lung cancer cells varies under tissue culture conditions, but epitopes in the C-terminal part of the precursor are more stable in plasma than the small GRP peptides and, thus, may serve as a better indicator than GRP itself for expression of the GRP precursor in cancer cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693372     DOI: 10.1210/jcem-70-6-1586

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Gastrin releasing peptide GRP(14-27) in human breast cancer cells and in small cell lung cancer.

Authors:  A J Vangsted; E V Andersen; L Nedergaard; J Zeuthen
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

2.  Expression of gastrin-releasing peptide is increased by prolonged stretch of human myometrium, and antagonists of its receptor inhibit contractility.

Authors:  Mark Tattersall; Yolande Cordeaux; D Stephen Charnock-Jones; Gordon C S Smith
Journal:  J Physiol       Date:  2012-03-12       Impact factor: 5.182

3.  Breast cancer cell-associated endopeptidase EC 24.11 modulates proliferative response to bombesin.

Authors:  D M Burns; B Walker; J Gray; J Nelson
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.